Noveome Biotherapeutics

About:

Noveome Biotherapeutics focuses on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.

Website: http://noveome.com/

Twitter/X: NoveomePgh

Top Investors: MAK Capital, Government of Pennsylvania

Description:

Noveome Biotherapeutics is a clinical-stage company focusing on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company's products contain a variety of biologic components at physiological concentrations that work together and synergistically to produce anti-inflammatory, neuroprotective, anti-apoptotic, and vascular integrity preservative properties.

Total Funding Amount:

$58.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)noveome.com

Founders:

George L. Sing, William Golden

Number of Employees:

11-50

Last Funding Date:

2023-08-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai